Jin Medical International Ltd. (ZJYL)
USD 0.8
(9.59%)
USD 0.8
(9.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.86 Million USD | 34.58% |
| 2022 | 2.13 Million USD | -19.04% |
| 2021 | 2.63 Million USD | 11.76% |
| 2020 | 2.35 Million USD | -46.53% |
| 2019 | 4.4 Million USD | 4.17% |
| 2018 | 4.22 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 614.61 Thousand USD | -43.91% |
| 2024 Q2 | 614.61 Thousand USD | 0.0% |
| 2023 Q4 | 1.09 Million USD | 100.0% |
| 2023 FY | 2.86 Million USD | 34.58% |
| 2023 Q1 | 885.72 Thousand USD | 59.02% |
| 2023 Q2 | 1.77 Million USD | 100.0% |
| 2023 Q3 | 547.9 Thousand USD | -69.07% |
| 2022 Q4 | 556.99 Thousand USD | 0.0% |
| 2022 Q3 | 556.99 Thousand USD | 9.59% |
| 2022 Q2 | 508.27 Thousand USD | -0.0% |
| 2022 Q1 | 508.27 Thousand USD | 28.89% |
| 2022 FY | 2.13 Million USD | -19.04% |
| 2021 Q4 | 394.34 Thousand USD | 0.0% |
| 2021 FY | 2.63 Million USD | 11.76% |
| 2021 Q3 | 394.34 Thousand USD | -57.2% |
| 2021 Q2 | 921.4 Thousand USD | 0.0% |
| 2021 Q1 | 921.4 Thousand USD | 55.99% |
| 2020 Q4 | 590.67 Thousand USD | 0.0% |
| 2020 FY | 2.35 Million USD | -46.53% |
| 2020 Q1 | 586.66 Thousand USD | -44.96% |
| 2020 Q2 | 586.66 Thousand USD | -0.0% |
| 2020 Q3 | 590.67 Thousand USD | 0.68% |
| 2019 Q1 | 1.13 Million USD | 0.0% |
| 2019 Q4 | 1.06 Million USD | 0.0% |
| 2019 Q2 | 1.13 Million USD | 0.0% |
| 2019 Q3 | 1.06 Million USD | -6.17% |
| 2019 FY | 4.4 Million USD | 4.17% |
| 2018 FY | 4.22 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 104.972% |
| AngioDynamics, Inc. | -97.71 Million USD | 102.934% |
| AtriCure, Inc. | -26.68 Million USD | 110.746% |
| Avinger, Inc. | -16.63 Million USD | 117.236% |
| Azenta, Inc. | -73.12 Million USD | 103.921% |
| BioLife Solutions, Inc. | -70.82 Million USD | 104.048% |
| The Cooper Companies, Inc. | 533.1 Million USD | 99.462% |
| Daxor Corporation | -177.07 Thousand USD | 1719.236% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 118.973% |
| Femasys Inc. | -14.5 Million USD | 119.763% |
| GlucoTrack, Inc. | -7.1 Million USD | 140.361% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -51.387% |
| Hologic, Inc. | 882.6 Million USD | 99.675% |
| ICU Medical, Inc. | 22.82 Million USD | 87.438% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 99.838% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 127.919% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 92.268% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 141.551% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 141.551% |
| Masimo Corporation | 136.5 Million USD | 97.899% |
| Microbot Medical Inc. | -9.85 Million USD | 129.094% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 80.462% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 97.687% |
| Nephros, Inc. | -1.59 Million USD | 279.991% |
| NovoCure Limited | -232.87 Million USD | 101.231% |
| NEXGEL, Inc. | -3.47 Million USD | 182.464% |
| NEXGEL, Inc. | -3.47 Million USD | 182.464% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 102.789% |
| OraSure Technologies, Inc. | 54.07 Million USD | 94.698% |
| Pro-Dex, Inc. | 7.17 Million USD | 60.027% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 106.58% |
| Predictive Oncology Inc. | -13.92 Million USD | 120.596% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 205.246% |
| QuidelOrtho Corporation | 139.1 Million USD | 97.939% |
| Repligen Corporation | 54.57 Million USD | 94.746% |
| Sanara MedTech Inc. | -4.21 Million USD | 168.023% |
| STAAR Surgical Company | 28.09 Million USD | 89.795% |
| Sharps Technology, Inc. | -10.12 Million USD | 128.314% |
| Utah Medical Products, Inc. | 16.77 Million USD | 82.91% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 103.373% |